Suburban Opioid Study (SOS)
郊区阿片类药物研究 (SOS)
基本信息
- 批准号:9232018
- 负责人:
- 金额:$ 34.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2020-09-29
- 项目状态:已结题
- 来源:
- 关键词:AddressAnalgesicsAreaAwarenessBayesian AnalysisBehaviorBostonCommunitiesConnecticutCrimeDataDemographyDisadvantagedDiseaseDrug usageDrug userEconomicsEnvironmentEpidemicEpidemiologyEthnic OriginEthnographyExposure toGenderGeographic LocationsGeographyGoalsHIVHIV/HCVHealthHealthcareHeroinHeroin AbuseHeroin UsersIndividualInfectionInjectableInjection of therapeutic agentInterventionInterviewKnowledgeLeadLocationMassachusettsMedicalMethodsMissionOpioidOverdosePatternPharmaceutical PreparationsPopulationPrevention programPrevention strategyPsyche structurePublic HealthQualitative MethodsRaceRecommendationRecording of previous eventsReportingResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesRiskRisk BehaviorsRouteRural CommunitySamplingServicesSexually Transmitted DiseasesSiteSkinSocial ClassSocial EnvironmentSoft Tissue InfectionsSuburban PopulationTimeUnited States National Institutes of HealthViolenceVirusWorkaddictioncohortdata visualizationdemographicsepidemiologic dataepidemiology studyethnic minority populationexperienceheroin overdoseimprovedinnovationintervention programlife historymortalitynonmedical usenovelopioid abuseopioid misuseopioid useoverdose deathprescription opioidpreventpublic health interventionpublic health relevanceracial and ethnicregional differencerural areasocialstemsuburbsuburban communitiestheoriestreatment programtrendurban area
项目摘要
Epidemiological data show a dramatic increase in opioid and heroin use, largely due to nonmedical use of
opioid prescription medications. Nationwide efforts to reduce diversion of prescription opioids appeared to
show a leveling of opioid overdose mortality rates but accompanied by a sharp increase in heroin overdose
mortality rates from 2012 to 2013. Unfortunately, despite increased focus on stopping the spread of the opioid
epidemic, the most recent data show both opioid and heroin use and overdose mortality rates are again
increasing. Opioid abuse has traversed social, economic, and geographic boundaries. The current opioid and
heroin crisis is like no other experienced in recent history. Most current heroin users started with physical
addiction to prescription opioids. Unlike previous cohorts of heroin users, the majority of new heroin users are
White, middle class, and live in nonurban areas. There is a lack of research on drug user populations in
suburban communities. The broad goal of this revised R15 application is to fill the gap in our understanding of
opioid and heroin use patterns in suburban communities where opioid use is epidemic. The study includes two
specific aims: (Aim 1) To examine opioid and heroin use initiation, trajectories, settings, situations, and risk
practices; (Aim 2) To compare opioid and heroin use patterns by race, ethnicity, and gender. Our qualitative
study triangulates ethnographic field research and in-depth interviews conducted in three suburban field sites
that differ by size, location, and demographics. The sample will consist of 180 opioid and/or heroin users living
in suburban communities around Boston, Massachusetts (N=60), New Haven, Connecticut (N=60), and
Atlanta, Georgia (N=60). We will use targeted, snowball, and theoretical sampling methods. Our novel use of
qualitative methods with Bayesian analysis and data visualizations to illustrate transition patterns in opioid and
heroin use among suburban populations is an innovation of this study design. Our collaborative and skilled
research team is led by multiple PIs and includes experienced investigators who have worked together
successfully on drug research projects. Our aims build on our previous suburban studies examining new trends
in suburban drug use and are a logical extension of our earlier research. This study responds to an urgent
need to know why opioid and heroin abuse continue to increase and what prevention and intervention
programs are needed to address the opioid epidemic. Our findings will inform health care efforts targeted to
suburban populations of opioid and heroin users. A more comprehensive understanding of suburban drug use,
risk environments, and social context can also inform larger epidemiological studies on opioid transitions, route
of administration practices, and other risk behaviors in diverse suburban areas where opioid and heroin use
are increasing.
流行病学数据显示,阿片类药物和海洛因的使用急剧增加,主要是由于非医疗使用,
阿片类处方药全国范围内减少处方阿片类药物转移的努力似乎
显示阿片类药物过量死亡率持平,但伴随着海洛因过量的急剧增加,
2012年至2013年的死亡率。不幸的是,尽管人们越来越关注阻止阿片类药物的传播,
流行病,最新数据显示,阿片类药物和海洛因的使用和过量死亡率再次
增加。阿片类药物滥用跨越了社会、经济和地理界限。目前的阿片类药物和
海洛因危机是近代史上从未有过的。目前大多数海洛因使用者开始与身体
处方阿片类药物成瘾与以前的海洛因使用者不同,大多数新的海洛因使用者是
白色,中产阶级,住在非城市地区。对吸毒人群缺乏研究,
郊区社区。修订后的R15应用程序的主要目标是填补我们对以下内容的理解上的差距:
在阿片类药物使用流行的郊区社区,阿片类药物和海洛因的使用模式。该研究包括两个
具体目标:(目标1)审查阿片类药物和海洛因使用的开始、轨迹、环境、情况和风险
(目的2)按种族、民族和性别比较阿片类药物和海洛因的使用模式。我们的质量
一项研究对在三个郊区实地进行的人种学实地研究和深入访谈进行了三角分析
大小、位置和人口统计数据不同。样本将包括180名阿片类药物和/或海洛因使用者,
在马萨诸塞州波士顿(N=60)、康涅狄格州纽黑文(N=60)和
亚特兰大,格鲁吉亚(N=60)。我们将使用目标抽样、滚雪球抽样和理论抽样方法。我们的新用途
使用贝叶斯分析和数据可视化的定性方法来说明阿片类药物和
在郊区人群中使用海洛因是本研究设计的一个创新。我们的协作和技术
研究团队由多名PI领导,包括经验丰富的研究人员,他们曾在一起工作
在药物研究项目上取得成功。我们的目标建立在我们以前的郊区研究,研究新的趋势
是我们早期研究的合理延伸这项研究回应了一个紧迫的问题,
需要知道为什么阿片类药物和海洛因滥用继续增加,以及什么预防和干预措施
需要制定计划来解决阿片类药物的流行问题。我们的研究结果将为针对以下目标的医疗保健工作提供信息:
阿片类药物和海洛因使用者的郊区人口。更全面地了解郊区吸毒情况,
风险环境和社会背景也可以为更大规模的阿片类药物过渡,途径
在阿片类药物和海洛因使用的不同郊区,
正在增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIRIAM W BOERI其他文献
MIRIAM W BOERI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIRIAM W BOERI', 18)}}的其他基金
Older Drug Users: A Life Course Study of Turning Points in Drug Use and Injection
老年吸毒者:吸毒和注射转折点的生命历程研究
- 批准号:
7660917 - 财政年份:2009
- 资助金额:
$ 34.16万 - 项目类别:
Methamphetamine Use in the Suburbs: An Exploratory Study
郊区甲基苯丙胺的使用:一项探索性研究
- 批准号:
7756542 - 财政年份:2007
- 资助金额:
$ 34.16万 - 项目类别:
Methamphetamine Use in the Suburbs: An Exploratory Study
郊区甲基苯丙胺的使用:一项探索性研究
- 批准号:
8266966 - 财政年份:2007
- 资助金额:
$ 34.16万 - 项目类别:
Methamphetamine Use in the Suburbs: An Exploratory Study
郊区甲基苯丙胺的使用:一项探索性研究
- 批准号:
7253065 - 财政年份:2007
- 资助金额:
$ 34.16万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 34.16万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 34.16万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 34.16万 - 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 34.16万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 34.16万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 34.16万 - 项目类别:














{{item.name}}会员




